🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Star Health and Allied Insurance Company Limited STARHEALTH NIFTY_SMALLNSEFINANCIAL

Financial Services · Insurance - Life · India
https://www.starhealth.in
Company Profile ↓
₹600.45
+40.57% 1Y
Mkt Cap₹35,330.69 Cr
P/E63.41
P/B4.64
52W High₹603.25
52W Low₹422.20
Book Value₹128.33
EPS (TTM)₹9.47

Company Overview

Star Health and Allied Insurance Company Limited provides health insurance products in India. It offers retail health insurance products for individuals, families, children, senior citizens, and persons with pre-existing medical conditions; group health insurance products for employer/employee and non-employer/employee groups, including small-to-medium enterprises; and personal accident and travel insurance products. The company also provides star women care insurance policy that provides surrogacy and oocyte donor covers; and star special care product that covers children diagnosed with autism and for outpatient specialized treatments. In addition, it offers star health assure insurance policy, star cancer care platinum insurance policy, senior citizens health insurance policy, and star cardiac care insurance policy – platinum, as well as star group OPD care insurance product. The company offers its products through web aggregators, digital channels, agency channels, corporate agents, brokers, point of salesperson, insurance marketing firms, and various other channels. Star Health and Allied Insurance Company was incorporated in 2005 and is based in Chennai, India.

Why Investors Should Care

Steady Revenue Expansion

Revenue has grown at a 13.3% CAGR over the past five years.

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.06.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Mar 2026 Revenue of ₹17,826.00 Cr (+10.7% YoY); net profit ₹556.98 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +10.7%, earnings -13.8%.
  • 5-Year Trend Long-term compounding — revenue CAGR 13.3%, profit CAGR -3.4%.

Growth & Price Performance

Compounded Sales Growth

5 Years:13.35%
1 Year:10.71%

Compounded Profit Growth

5 Years:-3.44%
1 Year:-13.76%

Stock Price Performance

1 Year:+40.57%
6 Months:+33.60%
3 Months:+20.90%
1 Month:+13.58%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 98% of range
₹422.20 ₹603.25
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)69.74 · Neutral
Price Performance
1M+13.58%
3M+20.90%
6M+33.60%
1Y+40.57%
Valuation vs Sector

P/E of 63.41 is above the sector median of 19.81 — pricier than peers.

Auto-generated from price history and fundamentals; not investment advice.

Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 13.3% over 5 years.
  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Trading at a high P/E of 63.4.
  • Earnings shrank at -3.4% CAGR over 5 years.

* The pros and cons are auto-generated from financial metrics.

Ad space

Valuation

Stock P/E
63.41
Industry PE
19.81
Forward P/E
22.80
PEG Ratio
-
Book Value
₹128.33
Price to Book
4.64
P/S
1.98
EV/EBITDA
43.75
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
13.35%
Profit 5Y
-3.44%
Revenue (YoY)
10.71%
Earnings (YoY)
-13.76%

Profitability & Returns

ROCE
-
ROE
7.38%
ROA
2.31%
Profit Margin
3.12%
Op Margin
5.20%
Gross Margin
21.22%
EPS (Latest Qtr)
₹1.89
EPS (TTM)
₹9.47

Balance Sheet & Liquidity

Debt/Equity
0.06
Quick Ratio
-
Current Ratio
-
Debt
₹470.00 Cr
Total Assets
₹24,063.77 Cr
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
64.11%
Chg in Prom Hold
-0.02%
FII / Inst Holding
23.87%
Chg in FII Hold
0.10%

Financial Snapshot

Enterprise Value
₹35,330.69 Cr
Total Revenue (TTM)
₹17,826.00 Cr
EBITDA
₹784.34 Cr
Free Cash Flow
₹1,795.33 Cr
Operating Cash Flow
-
Shares Outstanding
₹58.84 Cr
Gross Margin
21.22%
Payout Ratio
0.00%

Peer comparison

Peer companies in the same sector (Financial Services).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 STARHEALTH Star Health and Allied Insurance Company Limited NIFTY_SMALLNSEFINANCIAL 600.45 63.41 ₹35,330.69 Cr 0.00% - 7.38% 13.35% -3.44%
2 HDFCBANK HDFC Bank Limited NIFTY50NSEAIFINANCIAL 815.55 16.51 ₹12.48 L Cr 1.58% - 13.62% 32.50% 20.39%
3 ICICIBANK ICICI Bank Limited NIFTY50NSEAIFINANCIAL 1,423.10 19.03 ₹10.19 L Cr 0.86% - 14.93% 19.65% 16.78%
4 SBIN State Bank of India NIFTY50NSEAIFINANCIALPSU 1,031.00 11.31 ₹9.52 L Cr 1.67% - 13.97% 12.19% 14.39%
5 BAJFINANCE Bajaj Finance Limited NIFTY50NSEAIFINANCIAL 1,032.90 33.85 ₹6.43 L Cr 0.53% - 16.68% 22.58% 18.23%
6 LICI Life Insurance Corporation of India NIFTY_MIDNSEFINANCIALPSU 443.80 9.77 ₹5.61 L Cr 2.26% - 32.53% 7.26% 16.86%
7 AXISBANK Axis Bank Limited NIFTY50NSEAIFINANCIAL 1,340.20 15.86 ₹4.17 L Cr 0.08% - 12.27% 12.16% 34.61%
8 KOTAKBANK Kotak Mahindra Bank Limited NIFTY50NSEAIFINANCIAL 381.30 19.66 ₹3.79 L Cr 0.17% - 10.64% 13.48% 8.92%
9 BAJAJFINSV Bajaj Finserv Ltd. NIFTY50NSEAIFINANCIAL 1,887.10 34.31 ₹3.02 L Cr 0.07% - 12.58% 22.92% 15.16%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Sep 2024Dec 2024Mar 2025Jun 2025Dec 2025Mar 2026
Revenue -4,146.90 Cr4,081.13 Cr4,232.28 Cr4,566.62 Cr4,648.16 Cr
Cost of Revenue ------
Gross Profit ------
Operating Expenses ------
Operating Income ------
EBITDA ------
Interest Expense ------
Pretax Income -286.96 Cr-87.00 L352.02 Cr173.42 Cr151.21 Cr
Tax Provision -71.82 Cr-1.38 Cr89.50 Cr45.20 Cr39.87 Cr
Net Income -215.14 Cr51.00 L262.52 Cr128.22 Cr111.34 Cr
Diluted EPS -3.660.014.422.181.89

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue -12,241.10 Cr14,413.32 Cr16,102.06 Cr17,826.00 Cr
Cost of Revenue -----
Gross Profit -----
Operating Expenses -----
Operating Income -1,348.25 Cr914.82 Cr1,208.99 Cr926.47 Cr-
EBITDA -----
Interest Expense 48.38 Cr88.42 Cr80.14 Cr65.42 Cr-
Pretax Income -826.40 Cr1,128.85 Cr861.05 Cr754.33 Cr
Tax Provision -207.81 Cr283.84 Cr215.19 Cr197.34 Cr
Net Income -618.59 Cr845.01 Cr645.86 Cr556.98 Cr
Diluted EPS -10.4114.1910.869.47

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets -16,357.72 Cr18,054.33 Cr20,784.62 Cr24,063.77 Cr
Current Assets -----
Cash & Equivalents -309.36 Cr444.58 Cr668.43 Cr1,443.56 Cr
Inventory -----
Receivables 3.18 Cr3.15 Cr40.69 Cr53.39 Cr-
Total Liabilities -9,768.83 Cr11,322.54 Cr13,672.48 Cr16,512.55 Cr
Current Liabilities -----
Long Term Debt -470.00 Cr470.00 Cr470.00 Cr470.00 Cr
Total Debt -470.00 Cr470.00 Cr470.00 Cr470.00 Cr
Total Equity -6,588.89 Cr6,731.79 Cr7,112.14 Cr7,551.22 Cr
Shares Outstanding -58.17 Cr58.53 Cr58.78 Cr58.84 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow -----
Investing Cash Flow --1,097.13 Cr-1,176.71 Cr-1,150.58 Cr-1,066.85 Cr
Financing Cash Flow --268.02 Cr22.97 Cr-4.20 Cr-31.48 Cr
Capital Expenditure --46.59 Cr-123.49 Cr-82.71 Cr-78.11 Cr
Free Cash Flow -1,229.22 Cr1,186.47 Cr1,295.91 Cr1,795.33 Cr
Net Change in Cash --89.33 Cr156.22 Cr223.84 Cr775.11 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % -----
Operating Margin % -7.5%8.4%5.8%-
Net Margin % -5.1%5.9%4.0%3.1%
ROE % -9.4%12.6%9.1%7.4%
ROCE % -----

Shareholding Pattern

Insiders
64.11%
Institutions
23.87%
Public Float
66.50%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for STARHEALTH

Google News ue, 30 Jun 2026

Stock Radar: Star Health stock breaks out from multi-year resistance band to hit fresh 52-week high in Jun - The Economic Times

<a href="https://news.google.com/rss/articles/CBMinAJBVV95cUxPOFk0bEZ5QmxHWW01ZzVKV0ZwVjdON1UwTGVmRGtCVXVicHlZdE1iMkdUcFBVVWl0MDU5RGZFckt3WlRyNFduR3RsYzBlVzd5azdOUm9hbllacW5aSUlVbkNXeXZrMHBlLXlfNmY3TVI2MDBzbEpPUnlNZXMwaXhNaVJKVTF2Rjd1ZzFIZm…

Google News Mon, 16 Feb 2026

Star Health and Allied Insurance Company Limited (NSE:STARHEALTH) Not Flying Under The Radar - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi9wFBVV95cUxOT0lQbnpCVlRyV2plRGxfTndUa09yeFhLR3FFbWVqSFFNY2IyNXZYRkUyT0VGNGNJSERIWVNTUld4SVZFUHJnZ2wtSWluQURaSTJpcFpMZXFVS1ZOZlpob1JJeUNpdUxaVW1CbFF1LTAtd3h2MHdmaUVqSVpxXzJ6dGtHNzd5V1ItZ3d1ej…

Google News Wed, 25 Feb 2026

Star Health stock climbs 7%; Investec bullish on structural tailwinds - Business Standard

<a href="https://news.google.com/rss/articles/CBMi3gFBVV95cUxOM2ZKeWdnRGFiVnFrd3BXeTNrZjRMUU1zQ3ItajNPOFdXcDlCLUN4QUpzOFNmUE9DTFVmZzVqRk80SXJtblE5UFVRYWotQVM0QkxVRE8zWEoydnJhUlMzbHFabFhiMDBaMW1qUWlhcklVYTRTUklESzhJUERIZVAwVDhYSzF6ZENaTHVwZH…

Google News Fri, 19 Jun 2026

Star Health to host analyst meet on June 24 in Mumbai - scanx.trade

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxPdmpPU3YxNjR0ZmFUV01ZU09HajVVYTdVbVBHRDQ3MjF2S2NqYlNwVXVQRHdMaWo4NWpIN25UaWdKOVFpSHg5OGhfSHdKbkhmZm1MN1pjU3Jlc01QNTY4YU1GTUItTWxGam9EN0djQjVwS3BjakY3Mzg4OXRjTDlOd25fUlFuMFdtOTdNcy…

Google News hu, 18 Jun 2026

HOT STOCKS: CARYSIL Hits All-Time High; NIACL, KPRMILL, STARHEALTH, ICIL Lead Gainers; CENTUM, VBL, NBCC, APARINDS Among Top Losers While BEL, DMART, LUPIN Climb Above 50-SMA - MarketSmith India

<a href="https://news.google.com/rss/articles/CBMiowJBVV95cUxObGhGa1dQMmM1WWR0VVJPMVFHVFBBcUlKNXhjZHdtTk91Vy1oUzRUWTdrNzlJZFhwRkdLYnYxMXFLNVMtdkh2Rkk2ellfbnN1TXlZNXNyWmYycUpXaTFtQ3RvVDdrb0ZMV3ZJbWpuM0hOXzl3djQyT0VkazllNHBRd0x0ZUVLRjhwTDFIUU…

Google News ue, 14 Apr 2026

Star Health and Allied Insurance Company Ltd. Share Price Live Today - CNBC TV18

<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxQX3ZlNnIzOUNGT2ExS3YwNTBTRU1rM0R0Y2pvX0owX0FaNDB2LWFrbTV0RlNBS0dUR3c4MXBuLWhOdTdQY3NheHlfMVJ1TXR5aGJic01leXNXNVA3cE1rNVlKVnpEOHNOYng4RkdVaThDM015aU1ZMXdGenhsc1RaMkw5elcybGVJUnpJWW…

STARHEALTH — Frequently Asked Questions

What is the current share price of Star Health and Allied Insurance Company Limited (STARHEALTH)?

As of 2026-07-15 09:52 IST, Star Health and Allied Insurance Company Limited (STARHEALTH) trades at ₹600.45 on NSE. Its 52-week range is ₹422.20 to ₹603.25.

What is the market capitalisation of STARHEALTH?

Star Health and Allied Insurance Company Limited (STARHEALTH) has a market capitalisation of ₹35,330.69 Cr on NSE.

What is the P/E ratio of STARHEALTH?

STARHEALTH trades at a trailing price-to-earnings (P/E) ratio of 63.41. The industry average P/E is 19.81. Its price-to-book (P/B) ratio is 4.64.

What is the return on equity (ROE) of STARHEALTH?

STARHEALTH has a return on equity (ROE) of 7.38%.

Is STARHEALTH a good stock to buy?

This page provides a data-driven analysis of Star Health and Allied Insurance Company Limited (STARHEALTH), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Financial Services Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks